STOCK TITAN

[Form 3] West Pharmaceutical Services, Inc. Initial Statement of Beneficial Ownership

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
3
Rhea-AI Filing Summary

Envista Holdings Corporation (NVST) has filed a Form S-8 with the SEC to register an additional 6,425,000 shares of common stock for issuance under the company’s 2019 Omnibus Incentive Plan. The filing is made pursuant to General Instruction E, which allows a registrant to add securities to an existing employee benefit plan registration statement by incorporating prior S-8 filings (Nos. 333-233810, 333-262985 and 333-282219) by reference.

The shares may be issued as stock options, RSUs, or other equity awards to employees, officers and directors. No new capital is being raised, but the filing expands the share pool available for compensation programs, potentially increasing share count once awards vest or are exercised. Standard indemnification, incorporation-by-reference and undertaking clauses are included; the document contains no new financial results or operating guidance.

Envista Holdings Corporation (NVST) ha presentato un modulo S-8 alla SEC per registrare ulteriori 6.425.000 azioni ordinarie da emettere nell’ambito del Piano Incentivi Omnibus 2019 della società. La presentazione è effettuata in conformità all’Istruzione Generale E, che consente a un registrante di aggiungere titoli a una dichiarazione di registrazione esistente per piani di benefici ai dipendenti, incorporando per riferimento precedenti moduli S-8 (numeri 333-233810, 333-262985 e 333-282219).

Le azioni possono essere emesse sotto forma di opzioni azionarie, RSU o altri premi azionari a dipendenti, dirigenti e amministratori. Non viene raccolto nuovo capitale, ma la registrazione amplia il numero di azioni disponibili per i programmi di compensazione, potenzialmente aumentando il numero di azioni in circolazione una volta che i premi maturano o vengono esercitati. Sono incluse clausole standard di indennizzo, incorporazione per riferimento e impegno; il documento non contiene nuovi risultati finanziari o indicazioni operative.

Envista Holdings Corporation (NVST) ha presentado un Formulario S-8 ante la SEC para registrar 6.425.000 acciones ordinarias adicionales para su emisión bajo el Plan de Incentivos Omnibus 2019 de la compañía. La presentación se realiza conforme a la Instrucción General E, que permite a un registrante añadir valores a una declaración de registro existente para planes de beneficios para empleados incorporando por referencia presentaciones previas de S-8 (números 333-233810, 333-262985 y 333-282219).

Las acciones pueden emitirse como opciones sobre acciones, RSU u otras recompensas de capital para empleados, oficiales y directores. No se está recaudando nuevo capital, pero la presentación amplía el número de acciones disponibles para programas de compensación, aumentando potencialmente el recuento de acciones una vez que las recompensas se consoliden o ejerzan. Se incluyen cláusulas estándar de indemnización, incorporación por referencia y compromiso; el documento no contiene nuevos resultados financieros ni guías operativas.

Envista Holdings Corporation (NVST)는 회사의 2019년 옴니버스 인센티브 플랜에 따라 추가로 6,425,000주의 보통주를 발행하기 위해 SEC에 Form S-8을 제출했습니다. 이 제출은 기존 직원 복리후생 계획 등록 명세서에 증권을 추가할 수 있도록 하는 일반 지침 E에 따라 이루어졌으며, 이전의 S-8 제출서(번호 333-233810, 333-262985, 333-282219)를 참조로 포함합니다.

이 주식들은 직원, 임원 및 이사들에게 스톡 옵션, RSU 또는 기타 지분 보상으로 발행될 수 있습니다. 새로운 자본 조달은 없으나, 이 제출로 보상 프로그램에 사용할 수 있는 주식 풀이 확대되어 보상이 확정되거나 행사될 때 주식 수가 증가할 수 있습니다. 표준 면책, 참조 포함 및 약속 조항이 포함되어 있으며, 문서에는 새로운 재무 결과나 운영 지침이 포함되어 있지 않습니다.

Envista Holdings Corporation (NVST) a déposé un formulaire S-8 auprès de la SEC pour enregistrer 6 425 000 actions ordinaires supplémentaires à émettre dans le cadre du Plan d’Incitation Omnibus 2019 de la société. Ce dépôt est effectué conformément à l’Instruction Générale E, qui permet à un déclarant d’ajouter des titres à une déclaration d’enregistrement existante pour un plan d’avantages aux employés en incorporant par référence les dépôts S-8 antérieurs (numéros 333-233810, 333-262985 et 333-282219).

Les actions peuvent être émises sous forme d’options d’achat d’actions, d’unités d’actions restreintes (RSU) ou d’autres récompenses en actions aux employés, dirigeants et administrateurs. Aucun nouveau capital n’est levé, mais le dépôt augmente le nombre d’actions disponibles pour les programmes de rémunération, ce qui peut potentiellement accroître le nombre d’actions en circulation une fois que les récompenses sont acquises ou exercées. Des clauses standard d’indemnisation, d’incorporation par référence et d’engagement sont incluses ; le document ne contient pas de nouveaux résultats financiers ou de prévisions opérationnelles.

Envista Holdings Corporation (NVST) hat bei der SEC ein Formular S-8 eingereicht, um zusätzlich 6.425.000 Stammaktien zur Ausgabe im Rahmen des Omnibus-Anreizplans 2019 des Unternehmens zu registrieren. Die Einreichung erfolgt gemäß Allgemeiner Anweisung E, die es einem Registranten erlaubt, Wertpapiere zu einem bestehenden Registrierungsformular für Mitarbeiter-Benefit-Pläne hinzuzufügen, indem frühere S-8-Einreichungen (Nr. 333-233810, 333-262985 und 333-282219) durch Verweis einbezogen werden.

Die Aktien können als Aktienoptionen, RSUs oder andere Eigenkapitalvergütungen an Mitarbeiter, Führungskräfte und Direktoren ausgegeben werden. Es wird kein neues Kapital aufgenommen, aber die Einreichung erweitert den verfügbaren Aktienpool für Vergütungsprogramme, was potenziell die Aktienanzahl erhöht, sobald Auszeichnungen fällig werden oder ausgeübt werden. Standardmäßige Freistellungs-, Verweis- und Verpflichtungsklauseln sind enthalten; das Dokument enthält keine neuen finanziellen Ergebnisse oder operative Prognosen.

Positive
  • 6.425 million additional shares enhance the company’s ability to attract and retain talent through equity-based incentives, aligning employee interests with shareholders.
Negative
  • Potential dilution for existing investors if the newly registered shares are fully granted and subsequently converted to outstanding common stock.

Insights

TL;DR – Routine S-8 adds 6.425 M shares for employee equity; neutral impact, minor dilution risk.

This is an administrative registration that enlarges Envista’s equity compensation capacity. While additional shares can dilute existing holders when granted, S-8 filings do not involve cash fundraising and are common for mature issuers. Because no financial metrics, guidance changes, or strategic transactions accompany the filing, market impact should be modest and largely tied to investors’ views on dilution versus talent retention.

TL;DR – Filing strengthens incentive alignment but highlights ongoing reliance on equity awards.

Registering more shares supports long-term incentive structures that align management with shareholders. However, repeated share pool increases since 2019 may signal a heavy dependence on stock-based compensation, requiring careful oversight of burn rates and dilution limits under ISS/Glass Lewis policies. Overall governance posture remains standard, with robust indemnification and previously disclosed charter/by-law provisions.

Envista Holdings Corporation (NVST) ha presentato un modulo S-8 alla SEC per registrare ulteriori 6.425.000 azioni ordinarie da emettere nell’ambito del Piano Incentivi Omnibus 2019 della società. La presentazione è effettuata in conformità all’Istruzione Generale E, che consente a un registrante di aggiungere titoli a una dichiarazione di registrazione esistente per piani di benefici ai dipendenti, incorporando per riferimento precedenti moduli S-8 (numeri 333-233810, 333-262985 e 333-282219).

Le azioni possono essere emesse sotto forma di opzioni azionarie, RSU o altri premi azionari a dipendenti, dirigenti e amministratori. Non viene raccolto nuovo capitale, ma la registrazione amplia il numero di azioni disponibili per i programmi di compensazione, potenzialmente aumentando il numero di azioni in circolazione una volta che i premi maturano o vengono esercitati. Sono incluse clausole standard di indennizzo, incorporazione per riferimento e impegno; il documento non contiene nuovi risultati finanziari o indicazioni operative.

Envista Holdings Corporation (NVST) ha presentado un Formulario S-8 ante la SEC para registrar 6.425.000 acciones ordinarias adicionales para su emisión bajo el Plan de Incentivos Omnibus 2019 de la compañía. La presentación se realiza conforme a la Instrucción General E, que permite a un registrante añadir valores a una declaración de registro existente para planes de beneficios para empleados incorporando por referencia presentaciones previas de S-8 (números 333-233810, 333-262985 y 333-282219).

Las acciones pueden emitirse como opciones sobre acciones, RSU u otras recompensas de capital para empleados, oficiales y directores. No se está recaudando nuevo capital, pero la presentación amplía el número de acciones disponibles para programas de compensación, aumentando potencialmente el recuento de acciones una vez que las recompensas se consoliden o ejerzan. Se incluyen cláusulas estándar de indemnización, incorporación por referencia y compromiso; el documento no contiene nuevos resultados financieros ni guías operativas.

Envista Holdings Corporation (NVST)는 회사의 2019년 옴니버스 인센티브 플랜에 따라 추가로 6,425,000주의 보통주를 발행하기 위해 SEC에 Form S-8을 제출했습니다. 이 제출은 기존 직원 복리후생 계획 등록 명세서에 증권을 추가할 수 있도록 하는 일반 지침 E에 따라 이루어졌으며, 이전의 S-8 제출서(번호 333-233810, 333-262985, 333-282219)를 참조로 포함합니다.

이 주식들은 직원, 임원 및 이사들에게 스톡 옵션, RSU 또는 기타 지분 보상으로 발행될 수 있습니다. 새로운 자본 조달은 없으나, 이 제출로 보상 프로그램에 사용할 수 있는 주식 풀이 확대되어 보상이 확정되거나 행사될 때 주식 수가 증가할 수 있습니다. 표준 면책, 참조 포함 및 약속 조항이 포함되어 있으며, 문서에는 새로운 재무 결과나 운영 지침이 포함되어 있지 않습니다.

Envista Holdings Corporation (NVST) a déposé un formulaire S-8 auprès de la SEC pour enregistrer 6 425 000 actions ordinaires supplémentaires à émettre dans le cadre du Plan d’Incitation Omnibus 2019 de la société. Ce dépôt est effectué conformément à l’Instruction Générale E, qui permet à un déclarant d’ajouter des titres à une déclaration d’enregistrement existante pour un plan d’avantages aux employés en incorporant par référence les dépôts S-8 antérieurs (numéros 333-233810, 333-262985 et 333-282219).

Les actions peuvent être émises sous forme d’options d’achat d’actions, d’unités d’actions restreintes (RSU) ou d’autres récompenses en actions aux employés, dirigeants et administrateurs. Aucun nouveau capital n’est levé, mais le dépôt augmente le nombre d’actions disponibles pour les programmes de rémunération, ce qui peut potentiellement accroître le nombre d’actions en circulation une fois que les récompenses sont acquises ou exercées. Des clauses standard d’indemnisation, d’incorporation par référence et d’engagement sont incluses ; le document ne contient pas de nouveaux résultats financiers ou de prévisions opérationnelles.

Envista Holdings Corporation (NVST) hat bei der SEC ein Formular S-8 eingereicht, um zusätzlich 6.425.000 Stammaktien zur Ausgabe im Rahmen des Omnibus-Anreizplans 2019 des Unternehmens zu registrieren. Die Einreichung erfolgt gemäß Allgemeiner Anweisung E, die es einem Registranten erlaubt, Wertpapiere zu einem bestehenden Registrierungsformular für Mitarbeiter-Benefit-Pläne hinzuzufügen, indem frühere S-8-Einreichungen (Nr. 333-233810, 333-262985 und 333-282219) durch Verweis einbezogen werden.

Die Aktien können als Aktienoptionen, RSUs oder andere Eigenkapitalvergütungen an Mitarbeiter, Führungskräfte und Direktoren ausgegeben werden. Es wird kein neues Kapital aufgenommen, aber die Einreichung erweitert den verfügbaren Aktienpool für Vergütungsprogramme, was potenziell die Aktienanzahl erhöht, sobald Auszeichnungen fällig werden oder ausgeübt werden. Standardmäßige Freistellungs-, Verweis- und Verpflichtungsklauseln sind enthalten; das Dokument enthält keine neuen finanziellen Ergebnisse oder operative Prognosen.

SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Poussot Rodolphe Jean

(Last) (First) (Middle)
530 HERMAN O. WEST DRIVE

(Street)
EXTON PA 19341

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
07/23/2025
3. Issuer Name and Ticker or Trading Symbol
WEST PHARMACEUTICAL SERVICES INC [ WST ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
SVP, Strategy & Corporate Dev
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 252.908 D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Rst. Stock Unit (1) (1) Common Stock 764.7 $0 D
Rst. Stock Unit (2) (2) Common Stock 329.32 $0 D
Stock Option (Right to Buy) 02/20/2025(3) 02/20/2034 Common Stock 1,577 $350.18 D
Stock Option (Right to Buy) 02/18/2026(2) 02/18/2035 Common Stock 760 $211 D
Explanation of Responses:
1. This award vests in three equal installments beginning on February 20, 2025.
2. This award vests in four equal installments beginning on February 18, 2026.
3. This award vests in four equal installments beginning on February 20, 2025.
/s/ Louis Lalli, as an agent for Rodolphe Poussot 08/01/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many shares is Envista (NVST) registering in this Form S-8?

The filing registers 6,425,000 additional shares of NVST common stock.

Which plan does the S-8 relate to?

All shares are for the Envista Holdings Corporation 2019 Omnibus Incentive Plan.

Why did Envista use Form S-8?

Form S-8 is used to register securities offered under employee benefit plans; it streamlines issuance to employees and directors.

Does the filing include new earnings or guidance data?

No. The document is administrative and contains no financial results or forward-looking guidance.

Could the additional shares dilute current shareholders?

Yes. If the registered shares are issued and become outstanding, they will increase the share count and dilute existing holdings.
West Pharm Svcs

NYSE:WST

WST Rankings

WST Latest News

WST Latest SEC Filings

WST Stock Data

17.92B
71.47M
0.59%
97.33%
1.89%
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States
EXTON